Corcept Therapeutics Inc Earnings

Corcept Therapeutics Inc’s revenue jumped 18.7% since last year same period to $194.43Mn in the Q2 2025. On a quarterly growth basis, Corcept Therapeutics Inc has generated 23.67% jump in its revenue since last 3-months.

Corcept Therapeutics Inc’s net profit fell -0.96% since last year same period to $35.15Mn in the Q2 2025. On a quarterly growth basis, Corcept Therapeutics Inc has generated 73.25% jump in its net profits since last 3-months.

Corcept Therapeutics Inc’s net profit margin fell -16.56% since last year same period to 18.08% in the Q2 2025. On a quarterly growth basis, Corcept Therapeutics Inc has generated 40.09% jump in its net profit margins since last 3-months.

Corcept Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at 0.17 - a -10.46% fall from last quarter’s estimates.

Corcept Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at 0.17.

Corcept Therapeutics Inc’s earning per share (EPS) fell -100% since last year same period to 0 in the Q3 2025. This indicates that the Corcept Therapeutics Inc has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.